Biocon Banks on Weight-Loss Drugs, Ups Biosimilar Stake
Biocon's generics business surges 24% driven by weight-loss drugs liraglutide & semaglutide. CEO Siddharth Mittal reveals strategy to capture share of the booming $95 billion GLP-1 market.
Category : Search result: liraglutide
Obesity Drugs: Not Miracle Cures
Discover why revolutionary weight-loss drugs aren't magic bullets for India's obesity crisis. Learn about limitations, costs, and sustainable solutions.
Weight Loss Shots: Bengaluru Doctors Issue Warning
Bengaluru medical experts sound alarm on diabetes drugs being misused for weight loss, highlighting dangerous side effects and long-term health risks.
Page 1 of 1